ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00209833
Recruitment Status : Unknown
Verified September 2005 by Hannover Medical School.
Recruitment status was:  Active, not recruiting
First Posted : September 21, 2005
Last Update Posted : November 18, 2005
Sponsor:
Collaborators:
University of Ulm
Johann Wolfgang Goethe University Hospital
University Hospital Freiburg
Klinikum Augsburg
Humboldt-Universität zu Berlin
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Ghent
Medizinische Universitätsklinik Tübingen
Klinikum Hanover-Siloah Hospital
Ev. Krankenhaus Essen-Werden
Klinikum Wuppertal GmbH
Information provided by:
Hannover Medical School

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : September 2005
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):